The DOI matches its OpenAlex record; 12 of the 12 references it cites were found in a registry or an index.
Survival and Failure Patterns of High-Grade Gliomas After Three-Dimensional Conformal Radiotherapy
Abstract
PURPOSE: The goal of three-dimensional (3-D) conformal radiation is to increase the dose delivered to tumor while minimizing dose to surrounding normal brain. Previously it has been shown that even escalated doses of 70 to 80 Gy have failure patterns that are predominantly local. This article describes the failure patterns and survival seen with high-grade gliomas given 90 Gy using a 3-D conformal intensity-modulated radiation technique. PATIENTS AND METHODS: From April 1996 to April 1999, 34 patients with supratentorial high-grade gliomas were treated to 90 Gy. For those that recurred, failure patterns were defined in terms of percentage of recurrent tumor located within the high-dose region. Recurrences with more than 95% of their volume within the high-dose region were considered central; those with 80% to 95%, 20% to 80%, and less than 20% were considered in-field, marginal, and distant, respectively. RESULTS: The median age was 55 years, and median follow-up was 11.7 months. At time of analysis, 23 (67.6%) of 34 patients had developed radiographic evidence of recurrence. The patterns of failure were 18 (78%) of 23 central, three (13%) of 23 in-field, two (9%) of 23 marginal, and zero (0%) of 23 distant. The median survival was 11.7 months, with 1-year survival of 47.1% and 2-year survival of 12.9%. No significant treatment toxicities were observed. CONCLUSION: Despite dose escalation to 90 Gy, the predominant failure pattern in high-grade gliomas remains local. This suggests that close margins used in highly conformal treatments do not increase the risk of marginal or distant recurrences. Our results indicate that intensification of local radiotherapy with dose escalation is feasible and deserves further evaluation for high-grade gliomas.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Assumptions in the radiotherapy of glioblastoma
Hochberg, F. H., & Pruitt, A. (1980) · Neurology · doi:10.1212/wnl.30.9.907 · Cited by 992
Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma
Wallner, K. E., Galicich, J. H., Krol, G., Arbit, E., & Malkin, M. G. (1989) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(89)90941-3 · Cited by 782
Chang, C. H., Horton, J., Schoenfeld, D., Salazer, O., Perez-Tamayo, R., Kramer, S., Weinstein, A., Nelson, J. S., & Tsukada, Y. (1983) · Cancer · doi:10.1002/1097-0142(19830915)52:6<997::aid-cncr2820520612>3.0.co;2-2 · Cited by 598
Lee, S. W., Fraass, B. A., Marsh, L. H., Herbort, K., Gebarski, S. S., Martel, M. K., Radany, E. H., Lichter, A. S., & Sandler, H. M. (1999) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(98)00266-1 · Cited by 306
Self-citationFitzek, M. M., Thornton, A. F., Rabinov, J. D., Lev, M. H., Pardo, F. S., Munzenrider, J. E., Okunieff, P., Bussière, M., Braun, I., Hochberg, F. H., et al. (1999) · Journal of Neurosurgery · doi:10.3171/jns.1999.91.2.0251 · Cited by 256
Malignant astrocytomas: focal tumor recurrence after focal external beam radiation therapy
Liang, B. C., Thornton, A. F., Sandler, H. M., & Greenberg, H. S. (1991) · Journal of Neurosurgery · doi:10.3171/jns.1991.75.4.0559 · Cited by 192
Self-citationWerner‐Wasik, M., Scott, C., Nelson, D. F., Gaspar, L. E., Murray, K. J., Fischbach, J. A., Nelson, J. S., Weinstein, A. S., & Curran, W. J. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960415)77:8<1535::aid-cncr17>3.0.co;2-0 · Cited by 156
Outcome and patterns of failure following limited-volume irradiation for malignant astrocytomas
Garden, A. S., Maor, M. H., Yung, W. K. A., Bruner, J. M., Woo, S. Y., Moser, R. P., & Lee, Y.-Y. (1991) · Radiotherapy and Oncology · doi:10.1016/0167-8140(91)90143-5 · Cited by 136
A quantitative assessment of the addition of MRI to CT-based, 3-D treatment planning of brain tumors
Haken, R. K. T., Thornton, A. F., Sandler, H. M., Lavigne, M. L., Quint, D. J., Fraass, B. A., Kessler, M. L., & McShan, D. L. (1992) · Radiotherapy and Oncology · doi:10.1016/0167-8140(92)90018-p · Cited by 124
Self-citationFraass, B. A., Kessler, M. L., McShan, D. L., Marsh, L. H., Watson, B. A., Dusseau, W. J., Eisbruch, A., Sandler, H. M., & Lichter, A. S. (1999) · Seminars in Radiation Oncology · doi:10.1016/s1053-4296(99)80055-1 · Cited by 110
Self-citation
Cited by
Exciting New Advances in Neuro-Oncology: The Avenue to a Cure for Malignant Glioma
Van Meir, E. G., Hadjipanayis, C. G., Norden, A. D., Shu, H. K., Wen, P. Y., & Olson, J. J. (2010) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20069 · Cited by 1,372
Survival in glioblastoma: a review on the impact of treatment modalities
Delgado-López, P. D., & Corrales-García, E. M. (2016) · Clinical and Translational Oncology · doi:10.1007/s12094-016-1497-x · Cited by 659
Minniti, G., Amelio, D., Amichetti, M., Salvati, M., Muni, R., Bozzao, A., Lanzetta, G., Scarpino, S., Arcella, A., & Enrici, R. M. (2010) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2010.08.020 · Cited by 323
Hamstra, D. A., Chenevert, T. L., Moffat, B. A., Johnson, T. D., Meyer, C. R., Mukherji, S. K., Quint, D. J., Gebarski, S. S., Fan, X., Tsien, C. I., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508347102 · Cited by 287
Self-citationHamstra, D. A., Galbán, C. J., Meyer, C. R., Johnson, T. D., Sundgren, P. C., Tsien, C., Lawrence, T. S., Junck, L., Ross, D. J., Rehemtulla, A., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.2363 · Cited by 281
Self-citation
Metadata
- Authors
- Chan, J. L., Lee, S. W., Fraass, B. A., Normolle, D. P., Greenberg, H. S., Junck, L., Gebarski, S. S., & Sandler, H. M.
- Venue
- Journal of Clinical Oncology
- Publisher
- Lippincott Williams & Wilkins
- Published
- 2002-03-15
- Volume
- 20
- Issue
- 6
- Pages
- 1635-1642
- ISSN
- 0732-183X (ISSN-L)
- OpenAlex
- W2020784028
- Cited by
- 420
- References
- 12
- FWCI
- 5.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.